E-ISSN: 1308-5263
Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia [Turk J Hematol]
Turk J Hematol. 2024; 41(4): 288-290 | DOI: 10.4274/tjh.galenos.2024.2024.0231

Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia

Mehmet Sezgin Pepeler1, Simten Dağdaş1, Emel İşleyen1, Gaye Kalacı Katayıfçı1, Aydan Kılıçarslan1, Esra Özhamam1, Muhammed Talha Adakul2, Fahir Öztürk1, Funda Ceran1, Gülsüm Özet1
1University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye
2Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine (Intern), Ankara, Türkiye

Keywords: Daratumumab, Eltrombopag, Pure red cell aplasia, Acute lymphoblastic leukemia

ABO Kan Grubu Uyumsuz Allojenik Hematopoetik Kök Hücre Nakli Olan Hastada Gelişen Saf Eritroid Hücre Aplazisinde Daratumumab ve Eltrombopag Kullanımı

Mehmet Sezgin Pepeler1, Simten Dağdaş1, Emel İşleyen1, Gaye Kalacı Katayıfçı1, Aydan Kılıçarslan1, Esra Özhamam1, Muhammed Talha Adakul2, Fahir Öztürk1, Funda Ceran1, Gülsüm Özet1
1University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye
2Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine (Intern), Ankara, Türkiye

Anahtar Kelimeler: Daratumumab, Eltrombopag, Saf eritroid hücre aplazisi, Akut lenfoblastik lösemi

Corresponding Author: Mehmet Sezgin Pepeler, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE